Codexis Announces New Employment Inducement Grants

Core Points - Codexis, Inc. has approved equity grants for three new employees, which include options to purchase 137,950 shares and 27,000 restricted stock units (RSUs) under the 2024 Inducement Plan [1][2] Group 1: Equity Grants - The stock options have an exercise price equal to the closing price per share on the grant date and vest over four years, with 25% vesting on the first anniversary and the remainder vesting monthly thereafter [2] - The RSUs will vest in equal annual installments until the third anniversary of the grant date, contingent on the employees' continued service [2] Group 2: Company Overview - Codexis is a leading enzyme engineering company utilizing its proprietary CodeEvolver® technology platform to develop high-performance enzymes and proteins [4] - The company addresses challenges in small molecule pharmaceuticals manufacturing and nucleic acid synthesis, and is developing the ECO Synthesis™ platform for RNAi therapeutics [4] - Codexis' enzymes aim to improve yields, reduce energy usage and waste, enhance manufacturing efficiency, and increase sensitivity in genomic and diagnostic applications [4]